Dantrolene
RxNorm 3105
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 3105 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Dantrolene.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Dantrolene
(Atom ID: 12250460)
PTPrescribable
Designated preferred name (PT):
Dantrolene
(Atom ID: 92746)
FNPrescribable
Full form of descriptor (FN):
Dantrolene (substance)
(Atom ID: 92758)
PTPrescribable
Designated preferred name (PT):
Dantrolene-containing product
(Atom ID: 10800695)
FNPrescribable
Full form of descriptor (FN):
Product containing dantrolene (medicinal product)
(Atom ID: 9255750)
Patient Education
Dantrolene
Dantrolene is used to treat spasticity (muscle stiffness and tightness) or muscle spasms associated with spinal cord injuries, stroke, multiple sclerosis, or cerebral palsy. It is also used to prevent, treat, or reduce the risk of malignant hyperthermia (disorder that causes a fast rise in body temperature and muscle contractions), Dantrolene is in a class of medications called skeletal muscle relaxants. Dantrolene acts on the spinal cord nerves to treat spasticity and to prevent and treat malignant hyperthermia.
[Learn More]
* Please review the disclaimer below.